ArticleMolecular therapy. Methods & clinical development2017

Targeting Wnt/β-Catenin Activated Cells with Dominant-Negative N-cadherin to Reduce Neointima Formation.

Sarah Hulin-Curtis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.